Brain and Spine (Jan 2021)
Tumor-treating-fields therapy may influence the cerebrospinal fluid shunt valve settings in patients with high-grade glioma
- B. Sommer,
- I. Konietzko,
- M.N. Bonk,
- B. Hackanson,
- M. Trepel,
- K.H. Kahl,
- G. Stüben,
- C. Maurer,
- A. Berlis,
- T. Schaller,
- B. Märkl,
- E. Shiban
Affiliations
- B. Sommer
- University Hospital Augsburg, Department of Neurosurgery, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- I. Konietzko
- University Hospital Augsburg, Department of Neurosurgery, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- M.N. Bonk
- University Hospital Augsburg, Department of Neurosurgery, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- B. Hackanson
- University Hospital Augsburg, Department of Hematology and Oncology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- M. Trepel
- University Hospital Augsburg, Department of Hematology and Oncology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- K.H. Kahl
- University Hospital Augsburg, Department of Radiation Therapy, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- G. Stüben
- University Hospital Augsburg, Department of Radiation Therapy, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- C. Maurer
- University Hospital Augsburg, Department of Neuroradiology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- A. Berlis
- University Hospital Augsburg, Department of Neuroradiology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- T. Schaller
- University Hospital Augsburg, Department of Pathology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- B. Märkl
- University Hospital Augsburg, Department of Pathology, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- E. Shiban
- University Hospital Augsburg, Department of Neurosurgery, Augsburg, Germany; University Hospital Augsburg, ICCA (Interdisciplinary Comprehensive Cancer Center Augsburg), Augsburg, Germany
- Journal volume & issue
-
Vol. 1
p. 100499
